Google
Trusted Resources: News & Events
Latest announcements and gatherings
Study Suggests Ways of Improving Newborn Screening for Sickle Cell Disease
Researchers in Spain have defined cutoff points in hemoglobin measuring that can improve sensitivity and specificity to neonatal screening for sickle cell disease (SCD). Scientists can apply the method to diagnose other blood disorders, leading to better neonatal care.
Their report, “Impact of prematurity and immigration on neonatal screening for sickle cell disease,” appeared in the scientific journal PLOS One.
Measuring levels of different hemoglobins in infants is essential in diagnosing SCD. Previous research had described the relationship among hemoglobin A levels, the duration of the pregnancy, the baby’s gender and the mother’s ethnicity. However, those studies never defined normal cutoff points for different neonatal hemoglobins that took such factors into account, thereby compromising the sensitivity of these diagnostic tests.
+myBinderRelated Content
-
Indiana Sickle Cell Conference 2020 – VirtualThis one-day conference will provide hel...
-
Sickle Cell DiseaseSickle cell disease changes normal, roun...
-
What You Should Know About Sickle Cell Disease and PregnancyWhat should someone with sickle cell tra...
-
Darryl Watkins Stays Positive in Spite of Sickle Cell DiseaseDarryl Watkins has the HbSS variant of s...
-
Ty Montgomery says he’s not worried about sickle cell traitThe symptoms that kept Ty Montgomery out...
-
P.O.W.E.R ECHO Project Community Health Worker (CHW) Training – 3/21/24Cost: Free Monthly sessions 12–1 p.m...
-
Sickle cell gene linked to elevated risk of developing kidney failureNew research indicates that being born w...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.